Skip to main content
Journal cover image

Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials.

Publication ,  Journal Article
Folgar, FA; Jaffe, GJ; Ying, G-S; Maguire, MG; Toth, CA; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group,
Published in: Ophthalmology
October 2014

OBJECTIVE: To determine agreement between spectral-domain (SD) and time-domain (TD) optical coherence tomography (OCT) image assessments by certified readers in eyes treated for neovascular age-related macular degeneration (AMD). DESIGN: Cross-sectional study within the Comparison of AMD Treatments Trials (CATT). PARTICIPANTS: During year 2 of CATT, 1213 pairs of SD OCT and TD OCT scans were compared from a subset of 384 eyes. METHODS: Masked readers independently graded OCT scans for presence of intraretinal fluid (IRF), subretinal fluid (SRF), and sub-retinal pigment epithelium (RPE) fluid and performed manual measurements of retinal, SRF, and subretinal tissue complex thicknesses at the foveal center. MAIN OUTCOME MEASURES: Presence of fluid was evaluated with percent agreement, κ coefficients with 95% confidence intervals (CIs), and McNemar tests. Thickness measurements were evaluated with mean difference (Δ) ±95% limits of agreement and intraclass correlation coefficients (ICCs) with 95% CIs. RESULTS: Between SD OCT and TD OCT, agreement on presence of any fluid was 82% (κ = 0.46; 95% CI, 0.40-0.52), with 5% more SD OCT scans demonstrating fluid (P<0.001). Agreement on presence of SRF was 87% and sub-RPE fluid was 80%, with more SD OCT scans demonstrating fluid (both P < 0.001). Agreement on IRF was 73% (κ = 0.47; 95% CI, 0.42-0.52), with 6% more TD OCT scans demonstrating fluid (P < 0.001). Between SD OCT and TD OCT, mean thickness of the retina was Δ = 5±67 μm, SRF was Δ = 1.5±35 μm, and subretinal tissue complex was Δ = 5±86 μm. Thickness measurements were reproducible for retina (ICC = 0.84; 95% CI, 0.83-0.86), SRF (ICC = 0.88; 95% CI, 0.86-0.89), and subretinal tissue complex (ICC = 0.91; 95% CI, 0.89-0.92), with ≤25-μm difference in these measurements in 71%, 94%, and 61% of paired scans, respectively. CONCLUSIONS: Agreement on fluid presence and manual thickness measurements between paired scans from each OCT modality was moderate, providing a reasonable basis to compare CATT results with future SD OCT-based trials. Fluid was detected 5% more frequently with SD OCT, which may increase frequency of fluid-based treatment. Lower-resolution and artifactual interpretation of dark areas as cystoid edema may explain the greater frequency of IRF detected with TD OCT.

Duke Scholars

Published In

Ophthalmology

DOI

EISSN

1549-4713

Publication Date

October 2014

Volume

121

Issue

10

Start / End Page

1956 / 1965

Location

United States

Related Subject Headings

  • Tomography, Optical Coherence
  • Reproducibility of Results
  • Ranibizumab
  • Prospective Studies
  • Ophthalmology & Optometry
  • Macular Degeneration
  • Humans
  • Cross-Sectional Studies
  • Bevacizumab
  • Antibodies, Monoclonal, Humanized
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Folgar, F. A., Jaffe, G. J., Ying, G.-S., Maguire, M. G., Toth, C. A., & Comparison of Age-Related Macular Degeneration Treatments Trials Research Group, . (2014). Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials. Ophthalmology, 121(10), 1956–1965. https://doi.org/10.1016/j.ophtha.2014.04.020
Folgar, Francisco A., Glenn J. Jaffe, Gui-Shuang Ying, Maureen G. Maguire, Cynthia A. Toth, and Cynthia A. Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. “Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials.Ophthalmology 121, no. 10 (October 2014): 1956–65. https://doi.org/10.1016/j.ophtha.2014.04.020.
Folgar FA, Jaffe GJ, Ying G-S, Maguire MG, Toth CA, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2014 Oct;121(10):1956–65.
Folgar, Francisco A., et al. “Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials.Ophthalmology, vol. 121, no. 10, Oct. 2014, pp. 1956–65. Pubmed, doi:10.1016/j.ophtha.2014.04.020.
Folgar FA, Jaffe GJ, Ying G-S, Maguire MG, Toth CA, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2014 Oct;121(10):1956–1965.
Journal cover image

Published In

Ophthalmology

DOI

EISSN

1549-4713

Publication Date

October 2014

Volume

121

Issue

10

Start / End Page

1956 / 1965

Location

United States

Related Subject Headings

  • Tomography, Optical Coherence
  • Reproducibility of Results
  • Ranibizumab
  • Prospective Studies
  • Ophthalmology & Optometry
  • Macular Degeneration
  • Humans
  • Cross-Sectional Studies
  • Bevacizumab
  • Antibodies, Monoclonal, Humanized